Prasenjit Dey
Prasenjit Dey
Roswell Park Cancer Center
Verifierad e-postadress på roswellpark.org - Startsida
Citeras av
Citeras av
Genetics and biology of pancreatic ductal adenocarcinoma
H Ying, P Dey, W Yao, AC Kimmelman, GF Draetta, A Maitra, RA DePinho
Genes & development 30 (4), 355-385, 2016
Targeting YAP-dependent MDSC infiltration impairs tumor progression
G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ...
Cancer discovery 6 (1), 80-95, 2016
KRAS-IRF2 Axis Drives Immune Suppression andImmune Therapy Resistance in Colorectal Cancer
Cancer Cell 35 (2), 1-14, 2019
Genomic deletion of malic enzyme 2 confers collateral lethality in pancreatic cancer
P Dey, J Baddour, F Muller, CC Wu, H Wang, WT Liao, Z Lan, A Chen, ...
Nature 542 (7639), 119-123, 2017
Synthetic essentiality of chromatin remodelling factor CHD1 in PTEN-deficient cancer
D Zhao, X Lu, G Wang, Z Lan, W Liao, J Li, X Liang, JR Chen, S Shah, ...
Nature 542 (7642), 484-488, 2017
Estrogen Receptors β1 and β2 Have Opposing Roles in Regulating Proliferation and Bone Metastasis Genes in the Prostate Cancer Cell Line PC3
P Dey, P Jonsson, J Hartman, A Ström, JÅ Gustafsson
Molecular endocrinology 26 (12), 1991-2003, 2012
Estrogen receptor β upregulates FOXO3a and causes induction of apoptosis through PUMA in prostate cancer
P Dey, A Ström, JÅ Gustafsson
Oncogene 33 (33), 4213-4225, 2014
Insight into the mechanisms of action of estrogen receptor β in the breast, prostate, colon, and CNS
P Dey, RPA Barros, M Warner, A Ström, JÅ Gustafsson
Journal of molecular endocrinology 51 (3), T61-T74, 2013
Synthetic vulnerabilities of mesenchymal subpopulations in pancreatic cancer
G Genovese, A Carugo, J Tepper, FS Robinson, L Li, M Svelto, L Nezi, ...
Nature 542 (7641), 362-366, 2017
Targeting YAP-dependent MDSC infiltration impairs tumor progression. Cancer Discov. 2016; 6: 80–95. doi: 10.1158/2159-8290
G Wang, X Lu, P Dey, P Deng, CC Wu, S Jiang, Z Fang, K Zhao, ...
CD-15-0224.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 0
Oncogenic KRAS-Driven Metabolic Reprogramming in Pancreatic Cancer Cells Utilizes Cytokines from the Tumor MicroenvironmentCytokines Mediated Tumor Progression in PDAC
P Dey, J Li, J Zhang, S Chaurasiya, A Strom, H Wang, WT Liao, ...
Cancer discovery 10 (4), 608-625, 2020
PRKCI promotes immune suppression in ovarian cancer
S Sarkar, CA Bristow, P Dey, K Rai, R Perets, A Ramirez-Cardenas, ...
Genes & development 31 (11), 1109-1121, 2017
Antiproliferative effects and mechanisms of liver X receptor ligands in pancreatic ductal adenocarcinoma cells
NR Candelaria, S Addanki, J Zheng, T Nguyen-Vu, H Karaboga, P Dey, ...
PloS one 9 (9), e106289, 2014
Metabolic Codependencies in the Tumor MicroenvironmentMetabolic Codependencies in Cancer
P Dey, AC Kimmelman, RA DePinho
Cancer discovery 11 (5), 1067-1081, 2021
p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors.
Cancer Cell 35 (2), 204-220, 2019
Estrogen receptor β2 induces hypoxia signature of gene expression by stabilizing HIF-1α in prostate cancer
P Dey, LA Velazquez-Villegas, M Faria, A Turner, P Jonsson, P Webb, ...
PloS one 10 (5), e0128239, 2015
Epithelial memory of inflammation limits tissue damage while promoting pancreatic tumorigenesis
E Del Poggetto, IL Ho, C Balestrieri, EY Yen, S Zhang, F Citron, R Shah, ...
Science 373 (6561), eabj0486, 2021
Antioxidants and lipid peroxidation in gestational diabetes-a preliminary study
P Dey, P Gupta, NK Acharya, SN Rao, S Ray, S Chakrabarty, ...
Indian J Physiol Pharmacol 52 (2), 149-156, 2008
Telomere dysfunction activates YAP1 to drive tissue inflammation
D Chakravarti, B Hu, X Mao, A Rashid, J Li, J Li, W Liao, EM Whitley, ...
Nature communications 11 (1), 1-13, 2020
Fungal mycobiome drives IL-33 secretion and type 2 immunity in pancreatic cancer
A Alam, E Levanduski, P Denz, HS Villavicencio, M Bhatta, L Alhorebi, ...
Cancer cell 40 (2), 153-167. e11, 2022
Systemet kan inte utföra åtgärden just nu. Försök igen senare.
Artiklar 1–20